Nancy Khayat

Nancy Khayat is a seasoned professional in regulatory affairs with experience at notable companies such as FibroGen, Amgen, and Boehringer Ingelheim. Currently serving as a Senior Associate in Regulatory Affairs at FibroGen since May 2023, Nancy previously held the position of Senior Regulatory Affairs CMC Associate at Amgen and worked as a Regulatory Affairs Specialist in Labeling Operations at Boehringer Ingelheim, where responsibilities included ensuring compliance with FDA regulations, coordinating labeling document reviews, and maintaining internal databases. Nancy also has a strong research background, demonstrated during tenure as a Student Researcher at the University of Southern California, focusing on the challenges of repurposing Ivermectin. Educational qualifications include a Master’s degree in Management of Drug Development - Regulatory Sciences from the University of Southern California and a Bachelor’s degree in Pharmacy from the Lebanese American University.